TickerFacts.

Oaktree Acquisition Corp. III Life Sciences (OACC): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.43M
As of 2025-12-31
$1.18M
As of 2026-06-30
2024-12-31: $1.36M2025-12-31: $1.43M$1.43M
2024-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$1.43M+5.7%2026-03-26, Balance as of period end
2024-12-31$1.36Mn/a2026-03-26, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Oaktree Acquisition Corp. III Life Sciences (OACC)2025-12-31$1.43M+5.7%
Dynamix Corp III (DNMX)2025-12-31$1.33Mn/a
Blue Acquisition Corp/Cayman (BACC)2025-12-31$560.8Kn/a
Thayer Ventures Acquisition Corp II (TVAI)2025-12-31$0n/a
Bitcoin Infrastructure Acquisition Corp Ltd (BIXI)2025-12-31$2.30Mn/a
Translational Development Acquisition Corp. (TDAC)2025-12-31$29.8K-93.2%
Globa Terra Acquisition Corp (GTERA)2025-12-31$0n/a
Copley Acquisition Corp (COPL)2025-12-31$0n/a
Activate Energy Acquisition Corp. (AEAQ)2025-12-31$738.1Kn/a

Compare OACC, DNMX, BACC, TVAI side by side · Screen every company in Blank Checks ↗